Human ghrelin: A gastric hormone with cardiovascular properties

Agostino Virdis, Lilach O Lerman, Francesco Regoli, Lorenzo Ghiadoni, Amir Lerman, Stefano Taddei

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Ghrelin is a growth hormone-releasing peptide, isolated from the stomach. Researches in progress documented that ghrelin participates in the stimulation of the hypothalamus-pituitary-adrenal axis at the hypothalamic level and in the regulation of energy balance. Growth hormone-independent functions have been ascribed to ghrelin. Among others, a large body of literature demonstrated the presence of specific receptors for ghrelin, distributed at the level of cardiomyocytes and endothelial cells. Therefore, a link between ghrelin and cardiovascular system has been hypothesized and, then, demonstrated in both experimental and clinical studies. Ghrelin has largely documented cardiac beneficial effects, including protection from ischemia/reperfusion injury, attenuation of left ventricular remodeling following myocardial infarction, and improvement of left ventricular function. Exercise level in patients with chronic heart failure had also been seen. Ghrelin exerts these effects through several mechanisms, including the inhibition of apoptosis. At the level of blood vessels, ghrelin exerts a significant impact on vascular function. In particular, acutely infused, ghrelin reverses endothelial dysfunction by increasing NO availability and restores the endothelin-1/nitric oxide imbalance in the peripheral microcirculation of patients with metabolic syndrome. Antioxidant/anti-inflammatory effects, and-or an ameliorated insulin sensitivity are proposed mechanisms whereby ghrelin exerts its vascular protective actions. At higher doses, ghrelin also decreases blood pressure, by mechanisms that involve the modulation of sympathetic nervous system. This finding highlights the ghrelin system as a promising candidate for cardiovascular drug discovery.

Original languageEnglish (US)
Pages (from-to)52-58
Number of pages7
JournalCurrent Pharmaceutical Design
Volume22
Issue number1
StatePublished - Jan 1 2016

Fingerprint

Ghrelin
Stomach
Hormones
Blood Vessels
Ghrelin Receptor
Cardiovascular Agents
Ventricular Remodeling
Sympathetic Nervous System
Endothelin-1
Drug Discovery
Microcirculation
Cardiovascular System
Reperfusion Injury
Left Ventricular Function
Cardiac Myocytes
Growth Hormone
Hypothalamus
Insulin Resistance
Nitric Oxide
Anti-Inflammatory Agents

Keywords

  • Blood vessels
  • Endothelium
  • Ghrelin
  • Metabolic syndrome
  • Nitric oxide

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Human ghrelin : A gastric hormone with cardiovascular properties. / Virdis, Agostino; Lerman, Lilach O; Regoli, Francesco; Ghiadoni, Lorenzo; Lerman, Amir; Taddei, Stefano.

In: Current Pharmaceutical Design, Vol. 22, No. 1, 01.01.2016, p. 52-58.

Research output: Contribution to journalArticle

Virdis, A, Lerman, LO, Regoli, F, Ghiadoni, L, Lerman, A & Taddei, S 2016, 'Human ghrelin: A gastric hormone with cardiovascular properties', Current Pharmaceutical Design, vol. 22, no. 1, pp. 52-58.
Virdis, Agostino ; Lerman, Lilach O ; Regoli, Francesco ; Ghiadoni, Lorenzo ; Lerman, Amir ; Taddei, Stefano. / Human ghrelin : A gastric hormone with cardiovascular properties. In: Current Pharmaceutical Design. 2016 ; Vol. 22, No. 1. pp. 52-58.
@article{620b7bf85e4c4b8b9209251c310dee7d,
title = "Human ghrelin: A gastric hormone with cardiovascular properties",
abstract = "Ghrelin is a growth hormone-releasing peptide, isolated from the stomach. Researches in progress documented that ghrelin participates in the stimulation of the hypothalamus-pituitary-adrenal axis at the hypothalamic level and in the regulation of energy balance. Growth hormone-independent functions have been ascribed to ghrelin. Among others, a large body of literature demonstrated the presence of specific receptors for ghrelin, distributed at the level of cardiomyocytes and endothelial cells. Therefore, a link between ghrelin and cardiovascular system has been hypothesized and, then, demonstrated in both experimental and clinical studies. Ghrelin has largely documented cardiac beneficial effects, including protection from ischemia/reperfusion injury, attenuation of left ventricular remodeling following myocardial infarction, and improvement of left ventricular function. Exercise level in patients with chronic heart failure had also been seen. Ghrelin exerts these effects through several mechanisms, including the inhibition of apoptosis. At the level of blood vessels, ghrelin exerts a significant impact on vascular function. In particular, acutely infused, ghrelin reverses endothelial dysfunction by increasing NO availability and restores the endothelin-1/nitric oxide imbalance in the peripheral microcirculation of patients with metabolic syndrome. Antioxidant/anti-inflammatory effects, and-or an ameliorated insulin sensitivity are proposed mechanisms whereby ghrelin exerts its vascular protective actions. At higher doses, ghrelin also decreases blood pressure, by mechanisms that involve the modulation of sympathetic nervous system. This finding highlights the ghrelin system as a promising candidate for cardiovascular drug discovery.",
keywords = "Blood vessels, Endothelium, Ghrelin, Metabolic syndrome, Nitric oxide",
author = "Agostino Virdis and Lerman, {Lilach O} and Francesco Regoli and Lorenzo Ghiadoni and Amir Lerman and Stefano Taddei",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "22",
pages = "52--58",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Human ghrelin

T2 - A gastric hormone with cardiovascular properties

AU - Virdis, Agostino

AU - Lerman, Lilach O

AU - Regoli, Francesco

AU - Ghiadoni, Lorenzo

AU - Lerman, Amir

AU - Taddei, Stefano

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Ghrelin is a growth hormone-releasing peptide, isolated from the stomach. Researches in progress documented that ghrelin participates in the stimulation of the hypothalamus-pituitary-adrenal axis at the hypothalamic level and in the regulation of energy balance. Growth hormone-independent functions have been ascribed to ghrelin. Among others, a large body of literature demonstrated the presence of specific receptors for ghrelin, distributed at the level of cardiomyocytes and endothelial cells. Therefore, a link between ghrelin and cardiovascular system has been hypothesized and, then, demonstrated in both experimental and clinical studies. Ghrelin has largely documented cardiac beneficial effects, including protection from ischemia/reperfusion injury, attenuation of left ventricular remodeling following myocardial infarction, and improvement of left ventricular function. Exercise level in patients with chronic heart failure had also been seen. Ghrelin exerts these effects through several mechanisms, including the inhibition of apoptosis. At the level of blood vessels, ghrelin exerts a significant impact on vascular function. In particular, acutely infused, ghrelin reverses endothelial dysfunction by increasing NO availability and restores the endothelin-1/nitric oxide imbalance in the peripheral microcirculation of patients with metabolic syndrome. Antioxidant/anti-inflammatory effects, and-or an ameliorated insulin sensitivity are proposed mechanisms whereby ghrelin exerts its vascular protective actions. At higher doses, ghrelin also decreases blood pressure, by mechanisms that involve the modulation of sympathetic nervous system. This finding highlights the ghrelin system as a promising candidate for cardiovascular drug discovery.

AB - Ghrelin is a growth hormone-releasing peptide, isolated from the stomach. Researches in progress documented that ghrelin participates in the stimulation of the hypothalamus-pituitary-adrenal axis at the hypothalamic level and in the regulation of energy balance. Growth hormone-independent functions have been ascribed to ghrelin. Among others, a large body of literature demonstrated the presence of specific receptors for ghrelin, distributed at the level of cardiomyocytes and endothelial cells. Therefore, a link between ghrelin and cardiovascular system has been hypothesized and, then, demonstrated in both experimental and clinical studies. Ghrelin has largely documented cardiac beneficial effects, including protection from ischemia/reperfusion injury, attenuation of left ventricular remodeling following myocardial infarction, and improvement of left ventricular function. Exercise level in patients with chronic heart failure had also been seen. Ghrelin exerts these effects through several mechanisms, including the inhibition of apoptosis. At the level of blood vessels, ghrelin exerts a significant impact on vascular function. In particular, acutely infused, ghrelin reverses endothelial dysfunction by increasing NO availability and restores the endothelin-1/nitric oxide imbalance in the peripheral microcirculation of patients with metabolic syndrome. Antioxidant/anti-inflammatory effects, and-or an ameliorated insulin sensitivity are proposed mechanisms whereby ghrelin exerts its vascular protective actions. At higher doses, ghrelin also decreases blood pressure, by mechanisms that involve the modulation of sympathetic nervous system. This finding highlights the ghrelin system as a promising candidate for cardiovascular drug discovery.

KW - Blood vessels

KW - Endothelium

KW - Ghrelin

KW - Metabolic syndrome

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=84953426279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953426279&partnerID=8YFLogxK

M3 - Article

C2 - 26581223

AN - SCOPUS:84953426279

VL - 22

SP - 52

EP - 58

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 1

ER -